Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain
CompletedNot applicableNCT02157389
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Placebo and nocebo responses have mainly been studied in healthy humans for pharmacological rather than psychological interventions. Moreover, only few studies examined patients or tested how previous experience and attitudes affect placebo and nocebo responses. On the psychological level expectancy and classical conditioning have been identified as two primary mechanisms. Both seem to be important with classical conditioning potentially having more long-term effects and expectancy being more important in nocebo effects. There is some initial evidence from the investigators own research that patients may be more prone to these effects and the investigators have also shown that placebo effects may last up to several years after treatment. The investigators therefore examine previous attitudes to pharmacological interventions for chronic pain in patients with chronic back pain and subdivide them into groups with high of low belief in the respective treatment modality. The investigators then apply a pharmacological placebo and study the interaction between the prevailing attitude (implicit and explicit) and the placebo effect with respect to pain perception but also to neurobiological mechanisms using functional magnetic resonance imaging. In addition to expectancy, conditioning of placebo will be examined and the long-term effects of the intervention will be determined.
Study details
- Official title
- Psychobiological Mechanisms of Placebo and Nocebo Effects in the Treatment of Chronic Back Pain
- Conditions
- Chronic Lower Back Pain
- Healthy Control Subjects
- Interventions
- Other: Administration of a pharmacological placebo
- Sponsor
- Central Institute of Mental Health, Mannheim
- Start date
- 2012-07
- Primary completion
- 2014-12
- Sex
- All
- Age range
- from 18 Years to 75 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Germany
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Male and female human subjects with chronic back pain (chronic persistent and recurrent pain \> 6 months) * Age between 18 and 65 * Voluntary participation. Exclusion Criteria: * Acute or chronic somatic diseases and inflammatory, neuropathic or tumor-related pain * Acute and chronic mental disorders according to DSM-IV (except for comorbid anxiety or depression, which are frequent in chronic pain) * Insufficient German language skills * Cognitive limitations * Intake of opioid medication or tranquilizers * Metal implants or electric implants that cannot be removed * Pregnancy * Claustrophobia * History of epilepsy, brain trauma, or brain tumor
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02157389